Full Description
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications.
Contains 12 practice-oriented topics including obstructive sleep apnea and MAFLD; the interlink between MAFLD and polycystic ovary syndrome; pregnancy and MAFLD; MAFLD and gut microbiota; and more.
Provides in-depth clinical reviews of metabolic associated fatty liver disease, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Contents
Pathobiology of Metabolic-Associated Fatty Liver Disease
Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence
Lean Metabolic-Associated Fatty Liver Disease
Lipid Disorders and Metabolic-Associated Fatty Liver Disease
Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease
Metabolic-Associated Fatty Liver Disease and Diabetes: A Double Whammy
Metabolic-Associated Fatty Liver Disease and the Gut Microbiota
Metabolic-Associated Fatty Liver Disease and Sarcopenia
A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic[1]Associated Fatty Liver Disease
Pregnancy and Metabolic-Associated Fatty Liver Disease
The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome
Management of Metabolic-Associated Fatty Liver Disease
